Delaware		06-0865505
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)

One Colonial Road, Manchester, Connecticut,		06040
(Address of principal executive offices)		(zip code)

Common stock $.10 par value per share.
Total Shares outstanding November 14, 2002		16,016,930

						Page No.
Part I.		Financial Information
		Item 1.		Financial Statements
				Consolidated Condensed Balance Sheets		3
				Consolidated Condensed Statements of Income and Comprehensive Income		4-5
				Consolidated Condensed Statements of Cash Flows		6
				Notes to Consolidated Condensed Financial Statements		7-10
		Item 2.		Management’s Discussion and Analysis of Financial Condition and Results of Operations		11-16
		Item 3.		Quantitative and Qualitative Disclosures about Market Risk		16
		Item 4.		Controls and Procedures		16-17
Part II.		Other Information
		Item 1.		Legal Proceedings		17
		Item 6.		Exhibits and Reports on Form 8-K		17
Signature						18
Certifications						19-20
Exhibit Index						21

		September 30, 2002				December 31, 2001
ASSETS			(Unaudited)				(Restated See Note 6)
Current assets:
Cash and cash equivalents		$	1,384			$	955
Accounts receivable, net			44,853				35,458
Inventories:
Finished goods			11,501				10,408
Work in process			11,221				8,135
Raw materials and supplies			9,208				9,799
LIFO reserve			(483	)			(483	)
Total inventories			31,447				27,859
Income taxes receivable			—				611
Prepaid expenses			2,647				2,363
Net investment in discontinued operations			1,044				1,165
Assets held for sale			314				1,515
Deferred tax assets			2,200				2,014
Total current assets			83,889				71,940
Property, plant and equipment, at cost			152,036				138,976
Accumulated depreciation			(70,024	)			(61,187	)
			82,012				77,789
Other assets, net			39,182				37,788
Total assets		$	205,083			$	187,517
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt		$	9,111			$	9,473
Accounts payable			14,745				15,295
Accrued taxes			2,778				792
Accrued payroll and other compensation			7,323				3,144
Other accrued liabilities			6,312				6,929
Total current liabilities			40,269				35,633
Long-term debt			19,676				18,210
Deferred tax liabilities			6,808				6,818
Other long-term liabilities			7,579				8,273
Commitments and contingencies
Stockholders’ equity:
Preferred stock			—				—
Common stock			2,211				2,208
Capital in excess of par value			41,846				41,439
Retained earnings			154,917				144,631
Accumulated other comprehensive loss			(6,581	)			(8,053	)
			192,393				180,225
Treasury stock, at cost			(61,642	)			(61,642	)
Total stockholders’ equity			130,751				118,583
Total liabilities and stockholders’ equity		$	205,083			$	187,517

		Three Months Ended September 30,
		2002				2001
						(Restated See Note 6)
		(Unaudited)
Net sales		$	62,721			$	53,478
Cost of sales			46,505				39,087
Gross margin			16,216				14,391
Selling, product development and administrative expenses			11,458				11,168
Operating income			4,758				3,223
Other (income) expense:
Investment income			(14	)			(66	)
Interest expense			246				241
Foreign currency transaction gains, net			(84	)			(26	)
Other, net			20				90
			168				239
Income before income taxes			4,590				2,984
Income tax expense			1,324				682
Net income		$	3,266			$	2,302
Basic earnings per common share		$	.20			$	.14
Diluted earnings per common share		$	.20			$	.14
Weighted average common shares outstanding			16,011				15,917
Weighted average common shares and equivalents outstanding			16,335				16,024
Net income		$	3,266			$	2,302
Other comprehensive (loss) income, before tax:
Foreign currency translation adjustments			(82	)			737
Change in fair value of derivative instrument			(68	)			(140	)
Other comprehensive (loss) income, before tax			(150	)			597
Income tax benefit (expense) related to other comprehensive (loss) income			53				(209	)
Other comprehensive (loss) income, net of tax			(97	)			388
Comprehensive income		$	3,169			$	2,690

		Nine Months Ended September 30,
		2002				2001
						(Restated See Note 6)
		(Unaudited)
Net sales		$	188,665			$	170,683
Cost of sales			137,357				123,509
Gross margin			51,308				47,174
Selling, product development and administrative expenses			35,451				36,272
Impairment and restructuring charges			—				3,389
Operating income			15,857				7,513
Other (income) expense:
Investment income			(38	)			(157	)
Interest expense			631				817
Foreign currency transaction (gains) losses, net			(138	)			172
Other, net			(4	)			133
			451				965
Income from continuing operations before income taxes			15,406				6,548
Income tax expense			5,121				1,834
Income from continuing operations			10,285				4,714
Discontinued operations:
Loss from operations of discontinued segments, net of tax benefit of $181			—				(308